V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220009344 | 220012045 | 1.67 | 79.4 | Not known (9) | 2015-09-06 | 2015-09-06 | CISPLATIN + ETOPOSIDE | 02 | N | 220036439 | BUSULPHAN |
| 220009345 | 220003798 | null | -1 | Curative (C) | null | 2015-10-11 | FLUDARABINE | null | null | 220036440 | IPILIMUMAB |
| 220009346 | 220003798 | 1.75 | 3.5 | Palliative (P) | 2016-11-04 | 2016-11-04 | Ipilimumab | N | N | 220036440 | IPILIMUMAB |
| 220009347 | 220003798 | 1.66 | 0 | Not known (9) | 2018-03-03 | 2018-03-09 | CHOP R - 21 days | 2 | null | 220036440 | UKALL2014 |
| 220009348 | 220003798 | 0 | 80 | Curative (C) | null | 2016-05-03 | DAUNORUBICIN | N | N | 220036440 | BENDAMUSTINE + RITUXIMAB |
| 220009349 | 220003798 | 0 | 52.2 | Palliative (P) | 2015-03-09 | 2015-03-10 | Irinotecan + Modified De Gramont | N | N | 220036440 | IPILIMUMAB + NIVOLUMAB |
| 220009350 | 220003798 | 1.71 | 5.7 | Disease modification (D) | 2014-02-10 | 2014-02-10 | AML LI-1 Trial | 02 | N | 220036440 | PANITUMUMAB |
| 220009351 | 220003799 | 1.7 | 76.3 | Palliative (P) | 2018-01-22 | 2018-01-22 | BOSUTINIB | 02 | N | 220036449 | IPILIMUMAB + NIVOLUMAB |
| 220009352 | 220003800 | null | 49 | null | 2017-04-26 | 2017-04-26 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | N | Y | 220036453 | IMATINIB + HYDROXYCARBAMIDE |
| 220009353 | 220003801 | 1.76 | 88 | Curative (C) | null | 2015-05-18 | Ipilimumab | Y | N | 220036454 | ARSENIC TRIOXIDE + ATRA |
| 220009354 | 220003802 | 0 | 77.5 | Curative (C) | 2015-11-06 | 2015-11-07 | Mitoxantrone | 02 | N | 220036456 | CETUXIMAB + RT |
| 220009356 | 220012047 | 1.64 | 111 | Curative (C) | 2017-05-04 | 2017-05-04 | Carboplatin + Pemetrexed | N | N | 220036461 | GEMTUZUMAB OZOGAMICIN |
| 220009357 | 220003804 | null | null | Palliative (P) | 2017-04-22 | 2017-06-06 | IMATINIB + HYDROXYCARBAMIDE | 2 | null | 220036463 | CAPECITABINE |
| 220009358 | 220003804 | 1.7 | 74 | Curative (C) | 2013-01-04 | 2013-01-14 | CVP R | N | N | 220036463 | CYTARABINE INTRATHECAL |
| 220009359 | 220003804 | null | 29.7 | Curative (C) | 2016-08-12 | 2016-09-01 | Fludarabine + Melphalan RIC Allo | 02 | N | 220036463 | TRIPLE INTRATHECAL |
| 220009360 | 220019072 | 1.48 | null | null | 2013-06-16 | 2013-06-16 | UKALL14- Ph 2 Induction | N | null | 220036466 | ARSENIC TRIOXIDE |
| 220009361 | 220003805 | 1.63 | 67 | Curative (C) | null | 2014-11-13 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220036467 | CARBOPLATIN + RT |
| 220009362 | 220003805 | 1.68 | 75.5 | Curative (C) | 2013-08-25 | 2013-08-25 | ATG + Busulfan + Fludarabine | 02 | N | 220036467 | FBC |
| 220009366 | 220003807 | null | null | null | 2013-09-14 | 2013-09-30 | Capecitabine (21 day) + Irinotecan | N | N | 220036481 | ARSENIC TRIOXIDE |
| 220009367 | 220003807 | 1.68 | null | Palliative (P) | 2017-12-30 | 2018-01-27 | Fludarabine + Melphalan RIC Allo | N | N | 220036481 | ECARBOX |
| 220009368 | 220003807 | 1.63 | 0 | Not known (9) | 2013-10-15 | 2013-10-22 | VINCRISTINE | 2 | N | 220036481 | LENALIDOMIDE |
| 220009369 | 220019073 | 1.67 | null | Curative (C) | 2013-01-14 | 2013-01-15 | CYTARABINE + MITOXANTRONE | 02 | N | 220036490 | CYTARABINE + MITOXANTRONE |
| 220009370 | 220020531 | 1.6 | null | Curative (C) | 2017-01-01 | 2017-01-01 | LANREOTIDE | 02 | N | 220036491 | CYTARABINE + MITOXANTRONE |
| 220009371 | 220020531 | 0 | 90 | Palliative (P) | 2013-12-04 | 2013-12-05 | Arsenic Triox + Tretinoin Ind W1-4 | N | N | 220036491 | CAPECITABINE + TEMOZOLOMIDE |
| 220009372 | 220003808 | 1.97 | 80 | Disease modification (D) | 2017-10-24 | 2017-10-27 | CHOP - 21 days | N | N | 220036495 | PONATINIB |
| 220009373 | 220003808 | 1.82 | 82.9 | Palliative (P) | null | 2016-08-19 | Capecitabine + Cisplatin | N | N | 220036495 | CAPECITABINE + TEMOZOLOMIDE |
| 220009374 | 220003808 | 1.8 | 88.9 | Curative (C) | 2018-04-26 | 2018-04-28 | Ipilimumab | N | N | 220036495 | ALEMTUZUMAB |
| 220009375 | 220003808 | 1.68 | 97 | Palliative (P) | 2017-12-22 | 2017-12-22 | Bortezomib +/- Dexamethasone | 02 | N | 220036495 | DABRAFENIB |
| 220009376 | 220003808 | 1.55 | 8.7 | Curative (C) | 2017-03-24 | 2017-08-11 | IBRUTINIB | N | N | 220036495 | IDARUBICIN + MITOXANTRONE + TRETINOIN |
| 220009377 | 220003809 | 1.88 | 57 | Curative (C) | null | 2013-09-18 | Dacarbazine | N | N | 220036514 | FLUOROURACIL + MITOMYCIN + RT |
| 220009378 | 220003810 | 1.78 | 104.3 | Palliative (P) | 2016-03-18 | 2016-03-20 | Capecitabine | N | N | 220036517 | TEMOZOLOMIDE |
| 220009379 | 220003811 | 1.78 | 66.6 | Palliative (P) | 2016-06-17 | 2016-07-22 | Cisplatin + Etoposide + RT | N | N | 220036524 | VINCRISTINE |
| 220009380 | 220003812 | 1.92 | 124.8 | Palliative (P) | 2014-08-25 | 2014-08-25 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 220036525 | PACLITAXEL |
| 220009381 | 220003812 | 1.56 | 0 | Curative (C) | 2014-08-04 | 2014-08-17 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220036525 | ARSENIC TRIOXIDE |
| 220009382 | 220003812 | 1.75 | 65.9 | Disease modification (D) | 2016-12-05 | 2016-12-05 | Carboplatin + Liposomal Doxorubicin | N | N | 220036525 | THALIDOMIDE |
| 220009383 | 220019075 | 0 | 52.6 | Curative (C) | 2016-10-23 | 2016-11-15 | Carboplatin + Liposomal Doxorubicin | 2 | N | 220036528 | IDARUBICIN |
| 220009384 | 220003813 | null | 41.25 | Curative (C) | 2013-02-01 | 2013-02-05 | UKALL 14 TRIAL | N | N | 220036532 | METHOTREXATE INTRATHECAL |
| 220009385 | 220003813 | 1.68 | 47.4 | Palliative (P) | 2017-01-17 | 2017-01-22 | Paclitaxel 7 day | N | N | 220036532 | CISPLATIN + ETOPOSIDE |
| 220009386 | 220003813 | 1.68 | 111 | Not known (9) | 2016-06-26 | 2016-07-01 | Ipilimumab | 02 | N | 220036532 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220009387 | 220003813 | 1.82 | 0 | Curative (C) | 2015-04-30 | 2015-05-10 | CYTARABINE + MITOXANTRONE | N | N | 220036532 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220009388 | 220003814 | 1.57 | 67.9 | Palliative (P) | 2015-05-09 | 2015-05-27 | Cyclophosphamide oral | 02 | N | 220036539 | ROMAZA TRIAL |
| 220009389 | 220003815 | null | null | Curative (C) | 2016-08-19 | 2016-09-07 | PACLITAXEL | N | N | 220036540 | VIDE |
| 220009390 | 220003816 | 0 | 58.6 | Curative (C) | 2014-10-15 | 2014-10-15 | Mitoxantrone | 2 | N | 220036542 | CISPLATIN + FLUOROURACIL |
| 220009391 | 220003816 | null | null | Palliative (P) | 2014-02-09 | 2014-02-14 | Capecitabine + Streptozocin | null | null | 220036542 | CAPECITABINE + CARBOPLATIN |
| 220009392 | 220003816 | 1.72 | 87.2 | Curative (C) | 2014-02-06 | 2014-03-12 | Folfirinox | 02 | N | 220036542 | METHOTREXATE INTRATHECAL |
| 220009393 | 220003817 | 1.8 | 59.05 | Not known (9) | 2013-12-19 | 2013-12-19 | Dacarbazine | 02 | N | 220036548 | METHOTREXATE |
| 220009394 | 220012056 | 1.82 | 76 | Curative (C) | 2017-06-30 | 2017-07-13 | Cisplatin + Pemetrexed | 02 | N | 220036552 | TRIPLE INTRATHECAL |
| 220009395 | 220003818 | 1.75 | 89.5 | Palliative (P) | 2013-10-11 | 2013-10-11 | Dacarbazine | 02 | null | 220036556 | OCTREOTIDE |
| 220009396 | 220003818 | null | 111 | Curative (C) | 2014-08-30 | 2014-09-05 | Paclitaxel 80mg/m2 day 1 8 15 | 01 | N | 220036556 | CYCLOPHOSPHAMIDE |
| 220009397 | 220003818 | null | 68.3 | null | 2016-01-30 | 2016-01-31 | FLUDARABINE + MELPHALAN | N | null | 220036556 | CISPLATIN + DOCETAXEL + FLUOROURACIL |